Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1CNS 1

Conditions

Severe Combined Immunodeficiency 1Neuroblastoma 1Neoplasms 1Mucopolysaccharidosis I 1Hematologic Neoplasms 1

Interventions

Cyclophosphamide 8Flow Cytometry 6Methylprednisolone 5Melphalan 5Therapeutics 4Psychiatric Rehabilitation 4Busulfan 4Antilymphocyte Serum 4Radiotherapy 3Polymerase Chain Reaction 3Immunologic Techniques 3Filgrastim 3Caspofungin 3Amplified Fragment Length Polymorphism Analysis 3Alemtuzumab 3venetoclax 2thymoglobulin 2liposomal amphotericin B 2fludarabine phosphate 2fludarabine 2Whole-Body Irradiation 2Voriconazole 2Thiotepa 2Thalidomide 2Peripheral Blood Stem Cell Transplantation 2Ondansetron 2Nivolumab 2Itraconazole 2Ipilimumab 2Etoposide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neuroblastoma × Prospective Studies × Other hematologic neoplasm × Clear all
NCT00695279 2024-10-30

Long Term Follow Up Of Patients Who Have Received Gene Therapy Or Gene Marked Products

St. Jude Children's Research Hospital

Completed
41 enrolled
CNSOther hematologic neoplasm

Mucopolysaccharidosis I, Neoplasms, Neuroblastoma, Severe Combined Immunodeficiency, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡